RALY and fatty liver disease: The activation of LXR through pharmacologic intervention or a western diet induces the overexpression of hepatic LeXis. The interaction between LeXis and RALY inhibits the ability of the protein to bind to the cholesterol biosynthesis gene in the liver, which ameliorates hepatic steatosis.